Department of Public Health and Clinical Medicine, Skellefteå Research Unit (K.J., L.J., J.-H.J., M.M.L.), Umeå University, Sweden.
Department of Public Health and Clinical Medicine (J.P., S.S.), Umeå University, Sweden.
Stroke. 2020 Jul;51(7):2148-2152. doi: 10.1161/STROKEAHA.120.029630. Epub 2020 Jun 16.
Previous observational studies have shown a moderately increased risk of intracerebral hemorrhage (ICH) with high self-reported alcohol consumption. However, self-reported data tend to underestimate alcohol consumption. Phosphatidylethanol is a specific biomarker reflecting alcohol intake during the last month and correlates with the amount of alcohol consumed. The present study aimed to investigate the association between phosphatidylethanol levels and the risk of future ICH.
This population-based nested case-referent study was conducted within the Northern Sweden Health and Disease Cohort. At baseline, all participants underwent a health examination, including a questionnaire with questions about alcohol consumption. A blood sample was collected and stored at -80°C, and phosphatidylethanol 16:0/18:1 levels were measured in packed erythrocytes. Cases (n=97) were diagnosed with a first-ever ICH between 1985 and 2007. Two referents (n=180) were matched to each case.
The mean age at baseline was 55 years, 39% of participants were women, and the mean time from blood sampling to ICH was 7.3 years. Only phosphatidylethanol and hypertension remained independently associated with ICH in a multivariable model. Participants with phosphatidylethanol >0.30 μmol/L had an increased risk of ICH compared with those with phosphatidylethanol <0.01 μmol/L (odds ratio, 4.64 [95% CI, 1.49-14.40]).
High blood concentrations of phosphatidylethanol were associated with an increased risk of future ICH. This association was independent of hypertension and other risk factors for ICH. Our findings suggest that phosphatidylethanol, as a marker of alcohol consumption, may be used as a risk marker of future ICH.
先前的观察性研究表明,高自我报告饮酒量与颅内出血(ICH)风险中度增加相关。然而,自我报告的数据往往会低估饮酒量。磷脂酰乙醇是一种反映过去一个月内饮酒量的特异性生物标志物,与饮酒量相关。本研究旨在探讨磷脂酰乙醇水平与未来 ICH 风险之间的关系。
本基于人群的巢式病例对照研究在瑞典北部健康与疾病队列中进行。在基线时,所有参与者接受了健康检查,包括一份关于饮酒量的问卷。采集血样并在-80°C 下储存,在红细胞中测量磷脂酰乙醇 16:0/18:1 水平。病例(n=97)在 1985 年至 2007 年间被诊断为首次 ICH。每个病例匹配了 2 个对照(n=180)。
基线时的平均年龄为 55 岁,39%的参与者为女性,从采血到 ICH 的平均时间为 7.3 年。只有磷脂酰乙醇和高血压在多变量模型中与 ICH 独立相关。磷脂酰乙醇>0.30 μmol/L 的参与者发生 ICH 的风险高于磷脂酰乙醇<0.01 μmol/L 的参与者(比值比,4.64 [95%置信区间,1.49-14.40])。
血液中磷脂酰乙醇浓度升高与未来 ICH 风险增加相关。这种关联独立于高血压和其他 ICH 风险因素。我们的研究结果表明,磷脂酰乙醇作为饮酒的标志物,可作为未来 ICH 的风险标志物。